Publication details
Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders.
| Authors | |
|---|---|
| Year of publication | 2010 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Related projects: |